Goldenwell Biotech, Inc. (GWLL)
OTC Markets OTCQB
Fundamentals
Valuation and ratings
Goldenwell Biotech, Inc. trades at USD0.90. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc., engages in nutraceutical and dietary supplements business in the United States. It develops JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio.
The full research page for GWLL, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.